Paratek Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Paratek Pharmaceuticals

08/11/2021 23:17

* Paratek Pharmaceuticals Inc  PRTK.OQ  reported a quarterly
adjusted loss of 37 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 45 cents per share.
* Revenue rose 79% to $24.45 million from a year ago;  analysts
expected $23.82 million. 
* Paratek Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 37 cents​.
* The mean earnings estimate of analysts had fallen by
about 9.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Paratek Pharmaceuticals Inc shares had risen by 6.4% this
quarter and lost 17.4% so far this year.
* The company reported a quarterly loss of $18.2 million.
* Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $21.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 11:17 p.m.
 ​All figures in US dollars unless otherwise stated